课题基金 / 基金详情

BIOMOLECULES & ANALOGUES AS ANTIVIRAL/ANTITUMOR AGENTS

BIOMOLECULES & ANALOGUES AS ANTIVIRAL/ANTITUMOR AGENTS
生物分子
批准号:
3175658
负责人:
CARL RANDOLPH JOHNSON
金额:
$12.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-05-01 至 1993-04-30

项目摘要

项目成果

CARL RANDOLPH JOHNSON的其他基金

相似基金

相关文献

中文摘要
翻译
该计划的主旨是合成化合物,这些化合物 已知或具有作为抗肿瘤/抗病毒药物的潜力 适当的后续生物筛查。总体目标 包括: (I)开发有效的方法来合成几个 不寻常的,自然产生的核苷类似物,具有 抗肿瘤和/或抗病毒活性。 (Ii)新型核苷类似物的合成和筛选 通过类比被设计为可能的抗肿瘤/抗病毒药物 已知的生物活性物质或基于已知的或可能的 酶途径。 (Iii)多种化合物的合成和抗肿瘤活性的筛选 前列腺素和前列腺素代谢物的类似物。 (4)开发高效的生产方法 光学纯净的起始材料,特别是 二烷氧基环戊烯酮,应广泛用于 多种生物活性物质的对映专一性合成。 (V)开发普遍感兴趣的新的合成方法 有机合成。 (六)进一步论证材料的适用性 以及通过合成一系列额外的 生物感兴趣的目标。 优先目标包括碳环核苷类似物 在奈普罗星A的碳环上,设计了新的核苷 甲基转移酶的BE抑制剂,链的新变体 终止剂核苷类药物叠氮胸苷和双脱氧胞苷 关于目前对艾滋病治疗的兴趣,最近发现 抗病毒核苷、氧杂多辛和多种亲电剂 与前列腺素有关的环戊酮类化合物,设计用于 DNA聚合酶抑制剂。
英文摘要
The thrust of the program is the synthesis of compounds which are known or have potential as antitumor/antiviral agents with appropriate followup biological screening. The overall objectives are: (i) Development of efficient methods for the synthesis of several unusual, naturally occurring nucleosides analogues which have antitumor and/or antiviral activity. (ii) Synthesis and screening of novel nucleoside analogues designed as possible antitumor/antiviral agents by analogy with known bioactive substances or on the basis of known or probable enzymatic pathways. (iii) Synthesis and screening for antitumor activity of a variety of analogues of prostanoids and prostanoids metabolites. (iv) Development of efficient methods for the production of optically pure starting materials, particularly dialkoxycyclopentenones, which should be widely useful in enantiospecific syntheses of a variety of bioactive substances. (v) Development of new synthetic methods of general interest for organic synthesis. (vi) Further demonstration of the applicability of the materials and methods developed by synthesis of a selection of additional targets of biological interest. Targets of priority include carbocylic nucleoside analogues based on the carbocycle of neplanocin A, novel nucleosides designed to be inhibitors of methyltransferases, novel variations of the chain terminator nucleosides drugs azidothymidine and dideoxycytodine of current interest in AIDS therapy, the recently discovered antiviral nucleoside oxetanocin and a variety of electrophilic cyclopentenones related to prostanoids and designed to serve as DNA polymerase inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
3'4'-ALKYL NUCLEOSIDES--PROSPECTS FOR AIDS THERAPY
  • 批准号:
    2069932
  • 项目类别:
  • 资助金额:
    $12.19万
  • 财政年份:
    1993
  • 负责人:
    CARL RANDOLPH JOHNSON
  • 依托单位:
3'4'-ALKYL NUCLEOSIDES--PROSPECTS FOR AIDS THERAPY
  • 批准号:
    2069934
  • 项目类别:
  • 资助金额:
    $12.68万
  • 财政年份:
    1993
  • 负责人:
    CARL RANDOLPH JOHNSON
  • 依托单位:
3'4'-ALKYL NUCLEOSIDES--PROSPECTS FOR AIDS THERAPY
  • 批准号:
    2069933
  • 项目类别:
  • 资助金额:
    $12.33万
  • 财政年份:
    1993
  • 负责人:
    CARL RANDOLPH JOHNSON
  • 依托单位:
SYNTHESIS OF OPTICALLY PURE OXYGENATED CYCLOPENTANOIDS
  • 批准号:
    3175654
  • 项目类别:
  • 资助金额:
    $10.43万
  • 财政年份:
    1985
  • 负责人:
    CARL RANDOLPH JOHNSON
  • 依托单位:
海外基金